Captor Therapeutics Spolka Akcyjna Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Tom Shepherd
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.3yrs |
| CEO ownership | 1.3% |
| Management average tenure | no data |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
We Think Captor Therapeutics Spolka Akcyjna (WSE:CTX) Can Afford To Drive Business Growth
Mar 10
We're Not Worried About Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn
Oct 03Here's Why We're Not At All Concerned With Captor Therapeutics Spolka Akcyjna's (WSE:CTX) Cash Burn Situation
Mar 13Companies Like Captor Therapeutics Spolka Akcyjna (WSE:CTX) Can Afford To Invest In Growth
Jun 15CEO
Tom Shepherd
3.3yrs
Tenure
Dr. Thomas Shepherd, Ph D also known as Tom, is Chief Executive Officer at Captor Therapeutics spolka akcyjna and serves as Executive Chairman of Captor Therapeutics's Swiss affiliate, with responsibility...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Member of the Supervisory Board | 1.1yrs | no data | no data | |
| Chairman of the Supervisory Board | 5.8yrs | no data | 12.83% PLN 47.7m | |
| Independent Member of the Supervisory Board | 2.3yrs | no data | no data | |
| Independent Member of the Supervisory Board | no data | no data | 0.13% PLN 497.7k | |
| Member of the Supervisory Board | 3.2yrs | no data | 0.13% PLN 497.7k |
2.8yrs
Average Tenure
Experienced Board: CTX's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.